Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
OR2L9P (Olfactory receptor family 2 subfamily L member 9 pseudogene) is a pseudogene in the human genome, classified as a member of the olfactory receptor gene family[2][3][4]. While the olfactory receptors are typically responsible for odorant recognition and signal transduction in the sense of smell and are part of the large family of G protein-coupled receptors, OR2L9P is not believed to encode a functional protein due to accumulated mutations and disruption of the coding sequence, a status common to more than 70% of human olfactory receptor genes[2][6]. As a pseudogene, it does not have known biological function or disease roles, nor does it serve as a current target for therapy or marketed drugs. Key details: - OR2L9P is not a functional receptor and is not considered a drug target[2][3][4][6]. - It represents an example of the high proportion of olfactory receptor pseudogenes in humans, likely reflecting evolutionary loss of function due to reduced necessity for olfaction in primates[6]. - No interacting drugs, biomarkers, mechanisms of action, or safety concerns are relevant for OR2L9P due to its pseudogene status[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor family 2 subfamily L member 9 pseudogene (OR2L9P).